Form 4 Box 4 4 Precautions You Must Take Before Attending Form 4 Box 4
Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B Biol. Sci. 147, 258–267 (1957).
McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O’Garra, A. Blazon I interferons in communicable disease. Nat. Rev. Immunol. 15, 87–103 (2015).
Yan, N. & Chen, Z. J. Intrinsic antiviral immunity. Nat. Immunol. 13, 214–222 (2012).
Minn, A. J. Interferons and the immunogenic furnishings of blight therapy. Trends Immunol. 36, 725–737 (2015).
Barber, G. N. STING: infection, deepening and cancer. Nat. Rev. Immunol. 15, 760–770 (2015).
Zitvogel, L., Galluzzi, L., Kepp, O., Smyth, M. J. & Kroemer, G. Blazon I interferons in anticancer immunity. Nat. Rev. Immunol. 15, 405–414 (2015).
Crow, Y. J. & Manel, N. Aicardi–Goutieres affection and the blazon I interferonopathies. Nat. Rev. Immunol. 15, 429–440 (2015).
Ganguly, D. Do blazon I interferons articulation systemic autoimmunities and metabolic affection in a pathogenetic continuum? Trends Immunol. 39, 28–43 (2018).
Pestka, S., Krause, C. D. & Walter, M. R. Interferons, interferon-like cytokines, and their receptors. Immunol. Rev. 202, 8–32 (2004).
Stark, G. R. & Darnell, J. E. Jr. The JAK–STAT alleyway at twenty. Amnesty 36, 503–514 (2012).
Schreiber, G. & Piehler, J. The atomic base for anatomic bendability in blazon I interferon signaling. Trends Immunol. 36, 139–149 (2015).
Hartmann, G. Nucleic acerbic immunity. Adv. Immunol. 133, 121–169 (2017).
Goubau, D., Deddouche, S. & Reis e Sousa, C. Cytosolic assay of viruses. Amnesty 38, 855–869 (2013).
Andrejeva, J. et al. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and arrest its activation of the IFN-β promoter. Proc. Natl Acad. Sci. USA 101, 17264–17269 (2004).
Yoneyama, M. et al. The RNA helicase RIG-I has an capital action in double-stranded RNA-induced congenital antiviral responses. Nat. Immunol. 5, 730–737 (2004). This arrangement letters the assay of the role of RIG-I in antiviral immunity.
Kato, H. et al. Differential roles of MDA5 and RIG-I helicases in the acceptance of RNA viruses. Nature 441, 101–105 (2006). This abstraction demonstrates, application gene knockout in mice, non-redundant functions of RIG-I and MDA5 in virus sensing.
Gitlin, L. et al. Capital role of mda-5 in blazon I IFN responses to polyriboinosinic:polyribocytidylic acerbic and encephalomyocarditis picornavirus. Proc. Natl Acad. Sci. USA 103, 8459–8464 (2006).
Kowalinski, E. et al. Structural base for the activation of congenital allowed pattern-recognition receptor RIG-I by viral RNA. Corpuscle 147, 423–435 (2011). This assignment presents a clear anatomy of feature RIG-I absolute CARD2–helicase interactions in the abeyant conformation, and additionally provides a structural archetypal for RIG-I activation aloft RNA binding.
Jiang, F. et al. Structural base of RNA acceptance and activation by congenital allowed receptor RIG-I. Nature 479, 423–427 (2011).
Cui, S. et al. The C-terminal authoritative area is the RNA 5′-triphosphate sensor of RIG-I. Mol. Corpuscle 29, 169–179 (2008).
Luo, D. et al. Structural insights into RNA acceptance by RIG-I. Corpuscle 147, 409–422 (2011).
Berke, I. C. & Modis, Y. MDA5 cooperatively forms dimers and ATP-sensitive filaments aloft bounden double-stranded RNA. EMBO J. 31, 1714–1726 (2012).
Wu, B. et al. Structural base for dsRNA recognition, fiber formation, and antiviral arresting activation by MDA5. Corpuscle 152, 276–289 (2013).
Yu, Q., Qu, K. & Modis, Y. Cryo-EM structures of MDA5–dsRNA filaments at altered stages of ATP hydrolysis. Mol. Corpuscle 72, 999–1012.e6 (2018).
Binder, M. et al. Atomic apparatus of arresting acumen and affiliation by the congenital allowed sensor retinoic acid-inducible gene-I (RIG-I). J. Biol. Chem. 286, 27278–27287 (2011).
Peisley, A., Wu, B., Yao, H., Walz, T. & Hur, S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Corpuscle 51, 573–583 (2013).
Liu, G. et al. Nuclear-resident RIG-I senses viral archetype inducing antiviral immunity. Nat. Commun. 9, 3199 (2018).
Li, W., Chen, H., Sutton, T., Obadan, A. & Perez, D. R. Interactions amid the affliction A virus RNA polymerase apparatus and retinoic acid-inducible gene I. J. Virol. 88, 10432–10447 (2014).
Hornung, V. et al. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314, 994–997 (2006).
Pichlmair, A. et al. RIG-I-mediated antiviral responses to single-stranded RNA address 5′-phosphates. Science 314, 997–1001 (2006). This study, calm with the assignment by Hornung et al. (2006), shows that RIG-I recognizes RNA molecules with 5′-PPP groups and provides important acumen into the bigotry of viral and host RNAs.
Schlee, M. et al. Acceptance of 5′ triphosphate by RIG-I helicase requires abbreviate edgeless double-stranded RNA as absolute in batter of negative-strand virus. Amnesty 31, 25–34 (2009).
Schmidt, A. et al. 5′-Triphosphate RNA requires base-paired structures to actuate antiviral signaling via RIG-I. Proc. Natl Acad. Sci. USA 106, 12067–12072 (2009).
Goubau, D. et al. Antiviral amnesty via RIG-I-mediated acceptance of RNA address 5′-diphosphates. Nature 514, 372–375 (2014).
Schuberth-Wagner, C. et al. A conserved histidine in the RNA sensor RIG-I controls allowed altruism to N1-2′O-methylated cocky RNA. Amnesty 43, 41–51 (2015).
Lu, C. et al. The structural base of 5′ triphosphate double-stranded RNA acceptance by RIG-I C-terminal domain. Anatomy 18, 1032–1043 (2010).
Devarkar, S. C. et al. Structural base for m7G acceptance and 2′-O-methyl bigotry in capped RNAs by the congenital allowed receptor RIG-I. Proc. Natl Acad. Sci. USA 113, 596–601 (2016).
Zheng, J. et al. HDX-MS reveals dysregulated checkpoints that accommodation bigotry adjoin cocky RNA during RIG-I advised autoimmunity. Nat. Commun. 9, 5366 (2018).
Lassig, C. et al. ATP hydrolysis by the viral RNA sensor RIG-I prevents accidental acceptance of self-RNA. eLife 4, e10859 (2015).
Lassig, C. et al. Unified mechanisms for self-RNA acceptance by RIG-I Singleton–Merten affection variants. eLife 7, e38958 (2018).
Devarkar, S. C., Schweibenz, B., Wang, C., Marcotrigiano, J. & Patel, S. S. RIG-I uses an ATPase-powered translocation-throttling apparatus for active proofreading of RNAs and oligomerization. Mol. Corpuscle 72, 355–368.e4 (2018).
Wu, B. & Hur, S. How RIG-I like receptors actuate MAVS. Curr. Opin. Virol. 12, 91–98 (2015).
Ren, X., Linehan, M. M., Iwasaki, A. & Pyle, A. M. RIG-I selectively discriminates adjoin 5′-monophosphate RNA. Corpuscle Rep. 26, 2019–2027.e4 (2019).
Rehwinkel, J. et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Corpuscle 140, 397–408 (2010).
Baum, A., Sachidanandam, R. & Garcia-Sastre, A. Preference of RIG-I for abbreviate viral RNA molecules in adulterated beef appear by next-generation sequencing. Proc. Natl Acad. Sci. USA 107, 16303–16308 (2010).
Weber, M. et al. Incoming RNA virus nucleocapsids absolute a 5′-triphosphorylated genome actuate RIG-I and antiviral signaling. Corpuscle Host Microbe 13, 336–346 (2013).
Liu, G., Park, H. S., Pyo, H. M., Liu, Q. & Zhou, Y. Affliction a virus batter anatomy is anon circuitous in RIG-I activation and interferon induction. J. Virol. 89, 6067–6079 (2015).
Te Velthuis, A. J. W. et al. Mini viral RNAs act as congenital allowed agonists during affliction virus infection. Nat. Microbiol. 3, 1234–1242 (2018).
Chazal, M. et al. RIG-I recognizes the 5′ arena of dengue and Zika virus genomes. Corpuscle Rep. 24, 320–328 (2018).
Hertzog, J. et al. Infection with a Brazilian abstract of Zika virus generates RIG-I stimulatory RNA and the viral NS5 protein blocks blazon I IFN consecration and signaling. Eur. J. Immunol. 48, 1120–1136 (2018).
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M. Jr. Congenital amnesty induced by composition-dependent RIG-I acceptance of hepatitis C virus RNA. Nature 454, 523–527 (2008).
Rehwinkel, J. & Reis e Sousa, C. Targeting the viral Achilles’ heel: acceptance of 5′-triphosphate RNA in congenital anti-viral defence. Curr. Opin. Microbiol. 16, 485–492 (2013).
Chiang, J. J. et al. Viral apprehension of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat. Immunol. 19, 53–62 (2018). This abstraction demonstrates that virus infection can advance to the mislocalization and apprehension of cellular non-coding RNAs, consistent in RIG-I activation.
Zhao, Y., Ye, X., Dunker, W., Song, Y. & Karijolich, J. RIG-I like receptor assay of host RNAs facilitates the cell-intrinsic allowed acknowledgment to KSHV infection. Nat. Commun. 9, 4841 (2018). This arrangement letters the activation of RIG-I in KSHV-infected beef due to virus-induced defects in the accustomed post-transcriptional processing of cellular non-coding RNAs.
Samanta, M., Iwakiri, D., Kanda, T., Imaizumi, T. & Takada, K. EB virus-encoded RNAs are accustomed by RIG-I and actuate signaling to abet blazon I IFN. EMBO J. 25, 4207–4214 (2006).
Chiu, Y. H., Macmillan, J. B. & Chen, Z. J. RNA polymerase III detects cytosolic DNA and induces blazon I interferons through the RIG-I pathway. Corpuscle 138, 576–591 (2009).
Ablasser, A. et al. RIG-I-dependent assay of poly(dA:dT) through the consecration of an RNA polymerase III-transcribed RNA intermediate. Nat. Immunol. 10, 1065–1072 (2009).
Steiner, E., Holzmann, K., Elbling, L., Micksche, M. & Berger, W. Cellular functions of vaults and their captivation in multidrug resistance. Curr. Drug. Targets 7, 923–934 (2006).
Burke, J. M. & Sullivan, C. S. DUSP11 — an RNA phosphatase that regulates host and viral non-coding RNAs in beastly cells. RNA Biol. 14, 1457–1465 (2017).
Vabret, N. et al. Y-RNAs advance an autogenous affairs of RIG-I agonism mobilized aloft RNA virus infection and targeted by HIV. Preprint at bioRxiv https://doi.org/10.1101/773820 (2019).
Malathi, K., Dong, B., Gale, M. Jr. & Silverman, R. H. Baby self-RNA generated by RNase L amplifies antiviral congenital immunity. Nature 448, 816–819 (2007).
Zhao, L. et al. Identification of cellular microRNA-136 as a bifold regulator of RIG-I-mediated congenital amnesty that antagonizes H5N1 IAV archetype in A549 cells. Sci. Rep. 5, 14991 (2015).
Schmidt, N. et al. An affliction virus-triggered SUMO about-face orchestrates co-opted autogenous retroviruses to actuate host antiviral immunity. Proc. Natl Acad. Sci. USA 116, 17399–17408 (2019).
Dias Junior, A. G., Sampaio, N. G. & Rehwinkel, J. A acclimation act: MDA5 in antiviral amnesty and autoinflammation. Trends Microbiol. 27, 75–85 (2019).
Runge, S. et al. In vivo ligands of MDA5 and RIG-I in measles virus-infected cells. PLoS Pathog. 10, e1004081 (2014).
Sanchez David, R. Y. et al. Comparative assay of viral RNA signatures on altered RIG-I-like receptors. eLife 5, e11275 (2016).
Deddouche, S. et al. Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells. eLife 3, e01535 (2014).
Jang, M. A. et al. Mutations in DDX58, which encodes RIG-I, account aberant Singleton–Merten syndrome. Am. J. Hum. Genet. 96, 266–274 (2015).
Rutsch, F. et al. A specific IFIH1 gain-of-function alteration causes Singleton–Merten syndrome. Am. J. Hum. Genet. 96, 275–282 (2015).
Oda, H. et al. Aicardi–Goutieres affection is acquired by IFIH1 mutations. Am. J. Hum. Genet. 95, 121–125 (2014).
Rice, G. I. et al. Gain-of-function mutations in IFIH1 account a spectrum of animal ache phenotypes associated with upregulated blazon I interferon signaling. Nat. Genet. 46, 503–509 (2014). This assignment shows that mutations in the IFIH1 gene that encodes MDA5 account abnormal sensor activation and ache apprenticed by blazon I interferons.
Funabiki, M. et al. Autoimmune disorders associated with accretion of action of the intracellular sensor MDA5. Amnesty 40, 199–212 (2014).
Ahmad, S. et al. Breaching self-tolerance to Alu bifold RNA underlies MDA5-mediated inflammation. Corpuscle 172, 797–810.e13 (2018). This abstraction suggests that bifold RNAs basic from Alu elements actuate MDA5 in settings area either MDA5 is mutated or the RNA-editing agitator ADAR1 is impaired.
Smyth, D. J. et al. A genome-wide affiliation abstraction of nonsynonymous SNPs identifies a blazon 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat. Genet. 38, 617–619 (2006).
Sheng, Y. et al. Sequencing-based access articular three new susceptibility loci for psoriasis. Nat. Commun. 5, 4331 (2014).
Martinez, A. et al. Affiliation of the IFIH1–GCA–KCNH7 chromosomal arena with rheumatoid arthritis. Ann. Rheum. Dis. 67, 137–138 (2008).
Jin, Y. et al. Genome-wide affiliation analyses analyze 13 new susceptibility loci for ambiguous vitiligo. Nat. Genet. 44, 676–680 (2012).
Enevold, C. et al. Assorted sclerosis and polymorphisms of congenital arrangement acceptance receptors TLR1-10, NOD1-2, DDX58, and IFIH1. J. Neuroimmunol. 212, 125–131 (2009).
Cunninghame Graham, D. S. et al. Affiliation of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus. PLoS Genet. 7, e1002341 (2011).
Nejentsev, S., Walker, N., Riches, D., Egholm, M. & Todd, J. A. Rare variants of IFIH1, a gene active in antiviral responses, assure adjoin blazon 1 diabetes. Science 324, 387–389 (2009).
Dhir, A. et al. Mitochondrial double-stranded RNA triggers antiviral signalling in humans. Nature 560, 238–242 (2018). This abstraction indicates that mtRNA, back appear into the cytosol, activates MDA5.
Hartner, J. C., Walkley, C. R., Lu, J. & Orkin, S. H. ADAR1 is capital for the aliment of hematopoiesis and abolishment of interferon signaling. Nat. Immunol. 10, 109–115 (2009).
Rice, G. I. et al. Mutations in ADAR1 account Aicardi–Goutieres affection associated with a blazon I interferon signature. Nat. Genet. 44, 1243–1248 (2012).
Pestal, K. et al. Isoforms of RNA-editing agitator ADAR1 apart ascendancy nucleic acerbic sensor MDA5-driven autoimmunity and multi-organ development. Amnesty 43, 933–944 (2015).
Liddicoat, B. J. et al. RNA alteration by ADAR1 prevents MDA5 assay of autogenous dsRNA as nonself. Science 349, 1115–1120 (2015).
Chung, H. et al. Animal ADAR1 prevents autogenous RNA from triggering translational shutdown. Corpuscle 172, 811–824.e14 (2018).
Liu, H. et al. Tumor-derived IFN triggers abiding alleyway agonism and acuteness to ADAR loss. Nat. Med. 25, 95–102 (2019).
Ishizuka, J. J. et al. Accident of ADAR1 in tumours overcomes attrition to allowed checkpoint blockade. Nature 565, 43–48 (2019).
Gannon, H. S. et al. Identification of ADAR1 adenosine deaminase annex in a subset of blight cells. Nat. Commun. 9, 5450 (2018).
Nabet, B. Y. et al. Exosome RNA unshielding couples stromal activation to arrangement acceptance receptor signaling in cancer. Corpuscle 170, 352–366.e13 (2017).
Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is capital for RIG-I-mediated antiviral activity. Nature 446, 916–920 (2007).
Zeng, W. et al. Reconstitution of the RIG-I alleyway reveals a signaling role of afloat polyubiquitin chains in congenital immunity. Corpuscle 141, 315–330 (2010).
Peisley, A., Wu, B., Xu, H., Chen, Z. J. & Hur, S. Structural base for ubiquitin-mediated antiviral arresting activation by RIG-I. Nature 509, 110–114 (2014).
Liu, H. M. et al. The mitochondrial targeting babysitter 14–3–3ε regulates a RIG-I translocon that mediates film affiliation and congenital antiviral immunity. Corpuscle Host Microbe 11, 528–537 (2012).
Lian, H. et al. The zinc-finger protein ZCCHC3 binds RNA and facilitates viral RNA assay and activation of the RIG-I-like receptors. Amnesty 49, 438–448.e5 (2018). This assignment identifies that ZCCHC3 functions as a co-receptor for both RIG-I and MDA5.
Castanier, C. et al. MAVS ubiquitination by the E3 ligase TRIM25 and abasement by the proteasome is circuitous in blazon I interferon accumulation afterwards activation of the antiviral RIG-I-like receptors. BMC Biol. 10, 44 (2012).
Gack, M. U. et al. Affliction A virus NS1 targets the ubiquitin ligase TRIM25 to balk acceptance by the host viral RNA sensor RIG-I. Corpuscle Host Microbe 5, 439–449 (2009).
Chiang, C. et al. The animal papillomavirus E6 oncoprotein targets USP15 and TRIM25 to abolish RIG-I-mediated congenital allowed signaling. J. Virol. 92, e01737-17 (2018).
Koliopoulos, M. G. et al. Atomic apparatus of affliction A NS1-mediated TRIM25 acceptance and inhibition. Nat. Commun. 9, 1820 (2018).
Ban, J. et al. Animal respiratory syncytial virus NS 1 targets TRIM25 to abolish RIG-I ubiquitination and consecutive RIG-I-mediated antiviral signaling. Bacilli 10, 716 (2018).
Gupta, S. et al. Herpesvirus deconjugases arrest the IFN acknowledgment by announcement TRIM25 autoubiquitination and anatomic inactivation of the RIG-I signalosome. PLoS Pathog. 14, e1006852 (2018).
Manokaran, G. et al. Dengue subgenomic RNA binds TRIM25 to arrest interferon announcement for epidemiological fitness. Science 350, 217–221 (2015).
Chan, Y. K. & Gack, M. U. Viral artifice of intracellular DNA and RNA sensing. Nat. Rev. Microbiol. 14, 360–373 (2016).
Martin-Vicente, M., Medrano, L. M., Resino, S., Garcia-Sastre, A. & Martinez, I. TRIM25 in the adjustment of the antiviral congenital immunity. Front. Immunol. 8, 1187 (2017).
Sanchez, J. G. et al. The tripartite burden coiled-coil is an continued antiparallel ambit dimer. Proc. Natl Acad. Sci. USA 111, 2494–2499 (2014).
Sanchez, J. G. et al. Apparatus of TRIM25 catalytic activation in the antiviral RIG-I pathway. Corpuscle Rep. 16, 1315–1325 (2016).
Oshiumi, H. et al. The ubiquitin ligase Riplet is capital for RIG-I-dependent congenital allowed responses to RNA virus infection. Corpuscle Host Microbe 8, 496–509 (2010).
Oshiumi, H., Miyashita, M., Matsumoto, M. & Seya, T. A audible role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor area in animal antiviral congenital allowed responses. PLoS Pathog. 9, e1003533 (2013).
Rajsbaum, R. et al. Species-specific inhibition of RIG-I ubiquitination and IFN consecration by the affliction A virus NS1 protein. PLoS Pathog. 8, e1003059 (2012).
Gao, D. et al. REUL is a atypical E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One 4, e5760 (2009).
Cadena, C. et al. Ubiquitin-dependent and -independent roles of E3 Ligase RIPLET in congenital immunity. Corpuscle 177, 1187–1200.e16 (2019).
Vazquez, C., Tan, C. Y. & Horner, S. M. Hepatitis C virus infection is inhibited by a non-canonical antiviral signaling alleyway targeted by NS3–NS4A. J. Virol. https://doi.org/10.1128/JVI.00725-19 (2019).
Davis, M. E. & Gack, M. U. Ubiquitination in the antiviral allowed response. Virology 479–480, 52–65 (2015).
Xian, H. et al. Stratified ubiquitination of RIG-I creates able-bodied allowed acknowledgment and induces careful gene expression. Sci. Adv. 3, e1701764 (2017).
Wang, W. et al. RNF122 suppresses antiviral blazon I interferon accumulation by targeting RIG-I CARDs to arbitrate RIG-I degradation. Proc. Natl Acad. Sci. USA 113, 9581–9586 (2016).
Arimoto, K. et al. Abrogating adjustment of the RIG-I signaling by the ubiquitin ligase RNF125. Proc. Natl Acad. Sci. USA 104, 7500–7505 (2007).
Inn, K. S. et al. Linear ubiquitin accumulation circuitous abnormally regulates RIG-I- and TRIM25-mediated blazon I interferon induction. Mol. Corpuscle 41, 354–365 (2011).
Chen, W. et al. Consecration of Siglec-G by RNA bacilli inhibits the congenital allowed acknowledgment by announcement RIG-I degradation. Corpuscle 152, 467–478 (2013).
Brisse, M. & Ly, H. Comparative anatomy and action assay of the RIG-I-like receptors: RIG-I and MDA5. Front. Immunol. 10, 1586 (2019).
Wang, L. et al. USP4 absolutely regulates RIG-I-mediated antiviral acknowledgment through deubiquitination and stabilization of RIG-I. J. Virol. 87, 4507–4515 (2013).
Pauli, E. K. et al. The ubiquitin-specific protease USP15 promotes RIG-I-mediated antiviral signaling by deubiquitylating TRIM25. Sci. Signal. 7, ra3 (2014).
Gack, M. U., Nistal-Villan, E., Inn, K. S., Garcia-Sastre, A. & Jung, J. U. Phosphorylation-mediated abrogating adjustment of RIG-I antiviral activity. J. Virol. 84, 3220–3229 (2010).
Nistal-Villan, E. et al. Abrogating role of RIG-I serine 8 phosphorylation in the adjustment of interferon-β production. J. Biol. Chem. 285, 20252–20261 (2010).
Sun, Z., Ren, H., Liu, Y., Teeling, J. L. & Gu, J. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J. Virol. 85, 1036–1047 (2011).
Maharaj, N. P., Wies, E., Stoll, A. & Gack, M. U. Conventional protein kinase C-alpha (PKC-α) and PKC-β abnormally adapt RIG-I antiviral arresting transduction. J. Virol. 86, 1358–1371 (2012).
Wies, E. et al. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is capital for congenital allowed signaling. Amnesty 38, 437–449 (2013).
Takashima, K., Oshiumi, H., Takaki, H., Matsumoto, M. & Seya, T. RIOK3-mediated phosphorylation of MDA5 interferes with its accumulation and attenuates the congenital allowed response. Corpuscle Rep. 11, 192–200 (2015).
Davis, M. E. et al. Animosity of the phosphatase PP1 by the measles virus V protein is appropriate for congenital allowed escape of MDA5. Corpuscle Host Microbe 16, 19–30 (2014).
Jiang, X. et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral congenital allowed response. Amnesty 36, 959–973 (2012).
Lang, X. et al. TRIM65-catalized ubiquitination is capital for MDA5-mediated antiviral congenital immunity. J. Exp. Med. 214, 459–473 (2017).
Hu, M. M., Liao, C. Y., Yang, Q., Xie, X. Q. & Shu, H. B. Congenital amnesty to RNA virus is adapted by banausic and capricious sumoylation of RIG-I and MDA5. J. Exp. Med. 214, 973–989 (2017).
Nguyen, N. T., Now, H., Kim, W. J., Kim, N. & Yoo, J. Y. Ubiquitin-like modifier FAT10 attenuates RIG-I advised antiviral signaling by segregating activated RIG-I from its signaling platform. Sci. Rep. 6, 23377 (2016).
He, S. et al. Viral pseudo-enzymes actuate RIG-I via deamidation to balk cytokine production. Mol. Corpuscle 58, 134–146 (2015).
Choi, S. J. et al. HDAC6 regulates cellular viral RNA assay by deacetylation of RIG-I. EMBO J. 35, 429–442 (2016).
Liu, H. M. et al. Adjustment of retinoic acerbic inducible gene-I (RIG-I) activation by the histone deacetylase 6. EBioMedicine 9, 195–206 (2016).
Kok, K. H. et al. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate congenital antiviral response. Corpuscle Host Microbe 9, 299–309 (2011).
Luthra, P. et al. Mutual animosity amid the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Corpuscle Host Microbe 14, 74–84 (2013).
Lui, P. Y. et al. PACT facilitates RNA-induced activation of MDA5 by announcement MDA5 oligomerization. J. Immunol. 199, 1846–1855 (2017).
Pattabhi, S., Knoll, M. L., Gale, M. Jr. & Loo, Y. M. DHX15 is a coreceptor for RLR signaling that promotes antiviral aegis adjoin RNA virus infection. J. Interf. Cytok. Res. 39, 331–346 (2019).
Miyashita, M., Oshiumi, H., Matsumoto, M. & Seya, T. DDX60, a DEXD/H box helicase, is a atypical antiviral agency announcement RIG-I-like receptor-mediated signaling. Mol. Corpuscle Biol. 31, 3802–3819 (2011).
Oshiumi, H. et al. DDX60 is circuitous in RIG-I-dependent and absolute antiviral responses, and its action is attenuated by virus-induced EGFR activation. Corpuscle Rep. 11, 1193–1207 (2015).
Goubau, D. et al. Mouse superkiller-2-like helicase DDX60 is disposable for blazon I IFN consecration and amnesty to assorted viruses. Eur. J. Immunol. 45, 3386–3403 (2015).
Liu, Z. et al. NDR2 promotes the antiviral allowed acknowledgment via facilitating TRIM25-mediated RIG-I activation in macrophages. Sci. Adv. 5, eaav0163 (2019).
Chen, S. T. et al. NLRP12 regulates anti-viral RIG-I activation via alternation with TRIM25. Corpuscle Host Microbe 25, 602–616.e7 (2019). This abstraction reveals a atypical apparatus of coaction amid the NLR and RLR pathways.
Wang, P. et al. Caspase-12 controls West Nile virus infection via the viral RNA receptor RIG-I. Nat. Immunol. 11, 912–919 (2010).
Zhu, J. et al. Antiviral action of animal OASL protein is advised by acceptable signaling of the RIG-I RNA sensor. Amnesty 40, 936–948 (2014).
Lin, J. P., Fan, Y. K. & Liu, H. M. The 14–3–3η babysitter protein promotes antiviral congenital amnesty via facilitating MDA5 oligomerization and intracellular redistribution. PLoS Pathog. 15, e1007582 (2019).
Choudhury, N. R. et al. RNA-binding action of TRIM25 is advised by its PRY/SPRY area and is appropriate for ubiquitination. BMC Biol. 15, 105 (2017).
Sanchez, J. G. et al. TRIM25 binds RNA to attune cellular anti-viral defense. J. Mol. Biol. 430, 5280–5293 (2018).
Zhang, Q. & Cao, X. Epigenetic adjustment of the congenital allowed acknowledgment to infection. Nat. Rev. Immunol. 19, 417–432 (2019).
Ma, H. et al. The continued noncoding RNA NEAT1 exerts antihantaviral furnishings by acting as absolute acknowledgment for RIG-I signaling. J. Virol. 91, e02250-16 (2017).
Ingle, H. et al. The microRNA miR-485 targets host and affliction virus transcripts to adapt antiviral amnesty and bind viral replication. Sci. Signal. 8, ra126 (2015).
Xu, C. et al. Downregulation of microRNA miR-526a by enterovirus inhibits RIG-I-dependent congenital allowed response. J. Virol. 88, 11356–11368 (2014).
Zhu, B. et al. MicroRNA-15b modulates Japanese encephalitis virus-mediated deepening via targeting RNF125. J. Immunol. 195, 2251–2262 (2015).
Jiang, M. et al. Self-recognition of an inducible host lncRNA by RIG-I acknowledgment restricts congenital allowed response. Corpuscle 173, 906–919.e13 (2018). This assignment shows that a lncRNA represses RIG-I signalling through absolute alternation with the sensor.
Fan, J., Cheng, M., Chi, X., Liu, X. & Yang, W. A animal continued non-coding RNA LncATV promotes virus archetype through akin RIG-I-mediated congenital immunity. Front. Immunol. 10, 1711 (2019).
Lin, H. et al. The continued noncoding RNA Lnczc3h7a promotes a TRIM25-mediated RIG-I antiviral congenital allowed response. Nat. Immunol. 20, 812–823 (2019). This abstraction provides affirmation that a cellular non-coding RNA functions as a atomic arch to advance RIG-I–TRIM25 circuitous accumulation and RIG-I signalling.
Xie, Q. et al. Continued noncoding RNA ITPRIP-1 absolutely regulates the congenital allowed acknowledgment through advance of oligomerization and activation of MDA5. J. Virol. 92, e00507-18 (2018).
Atianand, M. K., Caffrey, D. R. & Fitzgerald, K. A. Immunobiology of continued noncoding RNAs. Annu. Rev. Immunol. 35, 177–198 (2017).
Valadkhan, S. & Plasek, L. M. Continued non-coding RNA-mediated adjustment of the interferon response: a new angle on a accustomed theme. Pathog. Immun. 3, 126–148 (2018).
Forster, S. C., Tate, M. D. & Hertzog, P. J. MicroRNA as blazon I interferon-regulated transcripts and modulators of the congenital allowed response. Front. Immunol. 6, 334 (2015).
Deretic, V., Saitoh, T. & Akira, S. Autophagy in infection, deepening and immunity. Nat. Rev. Immunol. 13, 722–737 (2013).
Du, Y. et al. LRRC25 inhibits blazon I IFN signaling by targeting ISG15-associated RIG-I for autophagic degradation. EMBO J. 37, 351–366 (2018).
Jounai, N. et al. The Atg5 Atg12 conjugate accumulation with congenital antiviral allowed responses. Proc. Natl Acad. Sci. USA 104, 14050–14055 (2007).
Lei, Y. et al. The mitochondrial proteins NLRX1 and TUFM anatomy a circuitous that regulates blazon I interferon and autophagy. Amnesty 36, 933–946 (2012).
Allen, I. C. et al. NLRX1 protein attenuates anarchic responses to infection by interfering with the RIG-I–MAVS and TRAF6–NF-κB signaling pathways. Amnesty 34, 854–865 (2011).
Sun, X. et al. MAVS maintains mitochondrial homeostasis via autophagy. Corpuscle Discov. 2, 16024 (2016).
Lee, N. R. et al. Activation of RIG-I-mediated antiviral signaling triggers autophagy through the MAVS–TRAF6–Beclin-1 signaling axis. Front. Immunol. 9, 2096 (2018).
Rodriguez, K. R., Bruns, A. M. & Horvath, C. M. MDA5 and LGP2: accomplices and antagonists of antiviral arresting transduction. J. Virol. 88, 8194–8200 (2014).
Rothenfusser, S. et al. The RNA helicase Lgp2 inhibits TLR-independent assay of viral archetype by retinoic acid-inducible gene-I. J. Immunol. 175, 5260–5268 (2005).
Quicke, K. M., Kim, K. Y., Horvath, C. M. & Suthar, M. S. RNA helicase LGP2 abnormally regulates RIG-I signaling by preventing TRIM25-mediated caspase activation and application area ubiquitination. J Interf. Cytok. Res. 39, 669–683 (2019).
Venkataraman, T. et al. Accident of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J. Immunol. 178, 6444–6455 (2007).
Bruns, A. M., Leser, G. P., Lamb, R. A. & Horvath, C. M. The congenital allowed sensor LGP2 activates antiviral signaling by acclimation MDA5–RNA alternation and fiber assembly. Mol. Corpuscle 55, 771–781 (2014).
Uchikawa, E. et al. Structural assay of dsRNA bounden to anti-viral arrangement acceptance receptors LGP2 and MDA5. Mol. Corpuscle 62, 586–602 (2016).
Parisien, J. P. et al. RNA sensor LGP2 inhibits TRAF ubiquitin ligase to abnormally adapt congenital allowed signaling. EMBO Rep. 19, e45176 (2018).
Suthar, M. S. et al. The RIG-I-like receptor LGP2 controls CD8 T corpuscle adaptation and fitness. Amnesty 37, 235–248 (2012). This abstraction identifies a arresting role for LGP2 in acclimation the acuteness of T beef to corpuscle death.
van der Veen, A. G. et al. The RIG-I-like receptor LGP2 inhibits Dicer-dependent processing of continued double-stranded RNA and blocks RNA arrest in beastly cells. EMBO J. 37, e97479 (2018).
Wu, Y., Wu, X., Wu, L., Wang, X. & Liu, Z. The anticancer functions of RIG-I-like receptors, RIG-I and MDA5, and their applications in blight therapy. Transl Res. 190, 51–60 (2017).
Roulois, D. et al. DNA-demethylating agents ambition colorectal blight beef by inducing viral assuming by autogenous transcripts. Corpuscle 162, 961–973 (2015).
Chiappinelli, K. B. et al. Inhibiting DNA methylation causes an interferon acknowledgment in blight via dsRNA including autogenous retroviruses. Corpuscle 162, 974–986 (2015).
Ranoa, D. R. et al. Blight therapies actuate RIG-I-like receptor alleyway through autogenous non-coding RNAs. Oncotarget 7, 26496–26515 (2016).
Kato, H. et al. Length-dependent acceptance of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J. Exp. Med. 205, 1601–1610 (2008).
Chiang, C. et al. Sequence-specific modifications enhance the broad-spectrum antiviral acknowledgment activated by RIG-I agonists. J. Virol. 89, 8011–8025 (2015).
Dassler-Plenker, J. et al. RIG-I activation induces the absolution of extracellular vesicles with antitumor activity. Oncoimmunology 5, e1219827 (2016).
Dassler-Plenker, J. et al. Absolute RIG-I activation in animal NK beef induces TRAIL-dependent cytotoxicity adjoin autologous melanoma cells. Int. J. Blight 144, 1645–1656 (2019).
Helms, M. W. et al. Utility of the RIG-I agonist triphosphate RNA for melanoma therapy. Mol. Blight Ther. https://doi.org/10.1158/1535-7163.MCT-18-1262 (2019).
Hochheiser, K. et al. Cutting edge: the RIG-I ligand 3pRNA potently improves CTL cross-priming and facilitates antiviral vaccination. J. Immunol. 196, 2439–2443 (2016).
Coch, C. et al. RIG-I activation protects and rescues from baleful affliction virus infection and bacterial superinfection. Mol. Ther. 25, 2093–2103 (2017).
Castiello, L. et al. An optimized retinoic acid-inducible gene I agonist M8 induces immunogenic corpuscle afterlife markers in animal blight beef and blooming corpuscle activation. Blight Immunol. Immunother. 68, 1479–1492 (2019).
Heidegger, S. et al. RIG-I activation is analytical for admiration to checkpoint blockade. Sci. Immunol. 4, eaau8943 (2019). This abstraction shows RIG-I activation by constructed RNAs as a ameliorative action to addition antitumour amnesty and reveals synergy with checkpoint blockade.
Jiang, X. et al. Intratumoral commitment of RIG-I agonist SLR14 induces able-bodied antitumor responses. J. Exp. Med. 216, 2854–2868 (2019).
Chen, Y. G. et al. Assay cocky and adopted annular RNAs by intron identity. Mol. Corpuscle 67, 228–238.e5 (2017).
Chen, Y. G. et al. N 6-methyladenosine modification controls annular RNA immunity. Mol. Corpuscle 76, 96–109.e9 (2019).
Wesselhoeft, R. A. et al. RNA circularization diminishes immunogenicity and can extend adaptation continuance in vivo. Mol. Corpuscle 74, 508–520.e4 (2019).
Luke, J. M. et al. Coexpressed RIG-I agonist enhances humoral allowed acknowledgment to affliction virus DNA vaccine. J. Virol. 85, 1370–1383 (2011).
Lazear, H. M. et al. Arrangement acceptance receptor MDA5 modulates CD8 T cell-dependent approval of West Nile virus from the axial afraid system. J. Virol. 87, 11401–11415 (2013).
Kandasamy, M. et al. RIG-I signaling is analytical for able polyfunctional T corpuscle responses during affliction virus infection. PLoS Pathog. 12, e1005754 (2016).
Stone, A. E. L., Green, R., Wilkins, C., Hemann, E. A. & Gale, M. Jr. RIG-I-like receptors absolute anarchic macrophage animosity adjoin West Nile virus infection. Nat. Commun. 10, 3649 (2019).
van Gent, M., Sparrer, K. M. J. & Gack, M. U. TRIM proteins and their roles in antiviral host defenses. Annu. Rev. Virol. 5, 385–405 (2018).
Versteeg, G. A. et al. The E3-ligase TRIM ancestors of proteins regulates signaling pathways triggered by congenital allowed pattern-recognition receptors. Amnesty 38, 384–398 (2013).
Ozato, K., Shin, D. M., Chang, T. H. & Morse, H. C. III. TRIM ancestors proteins and their arising roles in congenital immunity. Nat. Rev. Immunol. 8, 849–860 (2008).
Heaton, S. M., Borg, N. A. & Dixit, V. M. Ubiquitin in the activation and abrasion of congenital antiviral immunity. J. Exp. Med. 213, 1–13 (2016).
Carthagena, L. et al. Animal TRIM gene announcement in acknowledgment to interferons. PLoS One 4, e4894 (2009).
Mandell, M. A. et al. TRIM proteins adapt autophagy and can ambition autophagic substrates by absolute recognition. Dev. Corpuscle 30, 394–409 (2014).
Sparrer, K. M. J. et al. TRIM23 mediates virus-induced autophagy via activation of TBK1. Nat. Microbiol. 2, 1543–1557 (2017).
van Tol, S., Hage, A., Giraldo, M. I., Bharaj, P. & Rajsbaum, R. The TRIMendous role of TRIMs in virus–host interactions. Vaccines 5, 23 (2017).
Melchjorsen, J. et al. Early congenital acceptance of canker canker virus in animal primary macrophages is advised via the MDA5/MAVS-dependent and MDA5/MAVS/RNA polymerase III-independent pathways. J. Virol. 84, 11350–11358 (2010).
Nguyen, T. A. et al. SIDT2 transports extracellular dsRNA into the cytoplasm for congenital allowed recognition. Amnesty 47, 498–509.e6 (2017).
Zhao, J. et al. A viral deamidase targets the helicase area of RIG-I to block RNA-induced activation. Corpuscle Host Microbe 20, 770–784 (2016).
Duan, Y. et al. Nasopharyngeal blight progression is advised by EBER-triggered deepening via the RIG-I pathway. Blight Lett. 361, 67–74 (2015).
Samanta, M., Iwakiri, D. & Takada, K. Epstein–Barr virus-encoded baby RNA induces IL-10 through RIG-I-mediated IRF-3 signaling. Oncogene 27, 4150–4160 (2008).
Wang, F. et al. RIG-I mediates the co-induction of bump afterlife agency and blazon I interferon elicited by myxoma virus in primary animal macrophages. PLoS Pathog. 4, e1000099 (2008).
Pham, A. M. et al. PKR transduces MDA5-dependent signals for blazon I IFN induction. PLoS Pathog. 12, e1005489 (2016).
Pichlmair, A. et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. J. Virol. 83, 10761–10769 (2009).
Minamitani, T., Iwakiri, D. & Takada, K. Adenovirus virus-associated RNAs abet blazon I interferon announcement through a RIG-I-mediated pathway. J. Virol. 85, 4035–4040 (2011).
Watkinson, R. E., McEwan, W. A., Tam, J. C., Vaysburd, M. & James, L. C. TRIM21 promotes cGAS and RIG-I assay of viral genomes during infection by antibody-opsonized virus. PLoS Pathog. 11, e1005253 (2015).
Dou, Y., Yim, H. C., Kirkwood, C. D., Williams, B. R. & Sadler, A. J. The congenital allowed receptor MDA5 banned rotavirus infection but promotes corpuscle afterlife and pancreatic inflammation. EMBO J. 36, 2742–2757 (2017).
Uzri, D. & Greenberg, H. B. Characterization of rotavirus RNAs that actuate congenital allowed signaling through the RIG-I-like receptors. PLoS One 8, e69825 (2013).
Broquet, A. H., Hirata, Y., McAllister, C. S. & Kagnoff, M. F. RIG-I/MDA5/MAVS are appropriate to arresting a careful IFN acknowledgment in rotavirus-infected abdominal epithelium. J. Immunol. 186, 1618–1626 (2011).
Feng, Q. et al. MDA5 detects the double-stranded RNA replicative anatomy in picornavirus-infected cells. Corpuscle Rep. 2, 1187–1196 (2012).
Wang, J. P. et al. MDA5 and MAVS arbitrate blazon I interferon responses to coxsackie B virus. J. Virol. 84, 254–260 (2010).
Slater, L. et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the congenital acknowledgment to rhinovirus in bronchial epithelium. PLoS Pathog. 6, e1001178 (2010).
Cao, X. et al. MDA5 plays a analytical role in interferon acknowledgment during hepatitis C virus infection. J. Hepatol. 62, 771–778 (2015).
Fredericksen, B. L., Keller, B. C., Fornek, J., Katze, M. G. & Gale, M. Jr. Establishment and aliment of the congenital antiviral acknowledgment to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J. Virol. 82, 609–616 (2008).
Riedl, W. et al. Zika virus NS3 mimics a cellular 14–3–3-binding burden to alienate RIG-I- and MDA5-mediated congenital immunity. Corpuscle Host Microbe 26, 493–503.e6 (2019).
Zust, R. et al. Ribose 2′-O-methylation provides a atomic signature for the acumen of cocky and non-self mRNA abased on the RNA sensor Mda5. Nat. Immunol. 12, 137–143 (2011).
Zalinger, Z. B., Elliott, R., Rose, K. M. & Weiss, S. R. MDA5 is analytical to host aegis during infection with murine coronavirus. J. Virol. 89, 12330–12340 (2015).
Li, J., Liu, Y. & Zhang, X. Murine coronavirus induces blazon I interferon in oligodendrocytes through acceptance by RIG-I and MDA5. J. Virol. 84, 6472–6482 (2010).
Ikegame, S. et al. Both RIG-I and MDA5 RNA helicases accord to the consecration of α/β interferon in measles virus-infected animal cells. J. Virol. 84, 372–379 (2010).
Gitlin, L. et al. Melanoma differentiation-associated gene 5 (MDA5) is circuitous in the congenital allowed acknowledgment to Paramyxoviridae infection in vivo. PLoS Pathog. 6, e1000734 (2010).
Banos-Lara Mdel, R., Ghosh, A. & Guerrero-Plata, A. Analytical role of MDA5 in the interferon acknowledgment induced by animal metapneumovirus infection in blooming beef and in vivo. J. Virol. 87, 1242–1251 (2013).
Dutta, M. et al. A systems access reveals MAVS signaling in myeloid beef as analytical for attrition to Ebola virus in murine models of infection. Corpuscle Rep. 18, 816–829 (2017).
Cardenas, W. B. et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits α/β interferon accumulation induced by RIG-I signaling. J. Virol. 80, 5168–5178 (2006).
Solis, M. et al. RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated aloofness of RIG-I. J. Virol. 85, 1224–1236 (2011).
Ringeard, M., Marchand, V., Decroly, E., Motorin, Y. & Bennasser, Y. FTSJ3 is an RNA 2′-O-methyltransferase recruited by HIV to abstain congenital allowed sensing. Nature 565, 500–504 (2019).
Berg, R. K. et al. Genomic HIV RNA induces congenital allowed responses through RIG-I-dependent assay of secondary-structured RNA. PLoS One 7, e29291 (2012).
Lu, H. L. & Liao, F. Melanoma differentiation-associated gene 5 senses hepatitis B virus and activates congenital allowed signaling to abolish virus replication. J. Immunol. 191, 3264–3276 (2013).
Sato, S. et al. The RNA sensor RIG-I dually functions as an congenital sensor and absolute antiviral agency for hepatitis B virus. Amnesty 42, 123–132 (2015).
Form 4 Box 4 4 Precautions You Must Take Before Attending Form 4 Box 4 – form 1065 box 14
| Delightful to be able to my own weblog, in this moment I will teach you regarding keyword. Now, here is the primary impression: